Related case:
UFC 2017 Jon Jones vs USAD
September 13, 2018
In July 2016 the United States Anti-Doping Agency (USADA) has reported an anti-doping rule violation against the American MMA Athlete Jon Jones after his A and B samples tested positive for the prohibited substances Clomifene and Letrozole. After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the UFC Arbitration Panel.
The Athlete accepted the test resultts and denied the intentional use as a result of a contamined product. Analysis in the Salt Lake City Lab of the supplement Tadalafil he had used confirmed that it was contaminated with the prohibited substances.
USADA contended that there were errors, omissions and inconsistencies in the Athlete's testomony regarding the purchase and use of the supplement in question. Further he failed to mention the use of the product on the Doping Control Form.
Considering the evidence in this case the Panel finds that the Athlete managed to establish how the substances entered his system. The Panel concludes that the Athlete is not a drugs cheat and was unaware that the tablet he took contained prohibited substances. However the Panel finds that the Athlete acted with a high degree of fault since he failed to check the product before using.
Therefore the UFC Arbitration Panel decides on 6 November 2016 to impose a 1 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 6 July 2016 until 5 July 2017.